WhaleWatch logoWhaleWatch
Sign inStart for ₹1
Smart Money Alert
Beta Drugs Limited logo

Beta Drugs Limited

DecreasedQuarterly
BETAPharmaceuticalsMarket Cap₹1K Cr
Stake
12.47% → 11.04%
Holding
12.24 L shares
Change
−40,000 shares
As of
Jun 2026
Since alert−25.7%₹2,229.10 → ₹1,655.40
Nifty 50+6.0%
Ashish Kacholia
Ashish Kacholia
Investor
The move

Ashish Kacholia reduced his stake in Beta Drugs Limited from 12.47 percent to 11.04 percent, selling 40,000 shares across his holdings.

About Beta Drugs Limited
+ FollowVisit stock

A pharmaceutical manufacturer specializing in oncology drugs, Beta Drugs Ltd produces a comprehensive range of anti-cancer medications serving patients across India and international markets. The company operates through both domestic and export channels, distributing its products to institutional buyers, hospitals, and retail segments within the healthcare sector. Its focused expertise in oncology therapeutics and manufacturing capabilities position it within the critical healthcare segment addressing cancer treatment needs across emerging and established markets worldwide.

About Ashish Kacholia
+ FollowVisit investor

The 'Big Whale' of Dalal Street has an uncanny talent for spotting tomorrow's multibaggers today. Mumbai-based founder of Lucky Securities (ex-Hungama Digital co-founder with Rakesh Jhunjhunwala), Ashish Kacholia built his career at Prime Securities and Edelweiss before going full-time on his own book. His early calls on Skipper, Xpro India, and MTAR Technologies delivered 5-20x returns to investors who tracked his filings. He runs a ~₹2,370 Cr publicly disclosed portfolio across 49 stocks, almost entirely small- and mid-cap compounders picked for management quality and scalable business models. Find a quality small-cap before the crowd? Kacholia already owns it.

Get the next move the moment it happens.
Follow Ashish Kacholia and Beta Drugs Limited on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.
Explore
Beta Drugs Limited shareholdersAshish Kacholia's portfolioAll investorsAll stocks
🤖 We track their every move, post, interview and article. Obsessively.
⚡ Every move reaches your feed in minutes, while it still carries an edge
📊 Stake changes, bulk deals and insider trades, all tracked in one place
📰 A two-minute morning brief, so you start the day already ahead
Beta Drugs Limited
More moves in Beta Drugs Limited
Ashish KacholiaDecreased
Ashish Kacholia, through Suryavanshi Commotrade Private Limited, reduced his stake in Beta Drugs Limited from 11.04% to 10.54%, selling 51,119 shares.
14 Oct 2026
Read more
See all moves
Ashish Kacholia
More moves by Ashish Kacholia
2newest moves
Members only
Xxxxxx Xxxxxxxxxxxx xxxxxxx xxx xxxxx
Xxxxxxxx Xxxxxxxxxxxx xxxxx xx xxxxxxx
Unlock all 2 moves
Vasa DenticityExited
Ashish Kacholia has disappeared from the Vasa Denticity shareholder list after previously holding a 1.28 percent stake. This shift indicates that Ashish Kacholia either fully exited the position or trimmed it below the 1 percent reporting threshold.
DENTALKART20 Oct 2026
Read more
Xpro India LimitedDecreased
Ashish Kacholia sold 2,22,000 shares of Xpro India Limited for ₹21.54 Cr at ₹970.11 apiece in a bulk deal.
XPROINDIA19 Oct 2026
Read more
Knowledge Marine & Engineering Works LimitedDecreased
Ashish Kacholia trimmed his stake in Knowledge Marine & Engineering Works from 2.89% to 2.27%, selling 1,30,543 shares. He now holds 5,74,721 shares in the company.
KMEW19 Oct 2026
Read more
See all moves